Study finds mutations, DNA structures driving bladder cancer
October 11, 2024
October 11, 2024
ITHACA, New York, Oct. 11 -- Cornell University issued the following news:
A study led by researchers at Weill Cornell Medicine and the New York Genome Center illuminates as never before how bladder cancer originates and progresses.
The researchers found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development, and that standard chemotherapy is a potent source of mutations. The researchers also discovere . . .
A study led by researchers at Weill Cornell Medicine and the New York Genome Center illuminates as never before how bladder cancer originates and progresses.
The researchers found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development, and that standard chemotherapy is a potent source of mutations. The researchers also discovere . . .